Filing
Spy
Filing
Spy
Home
About
AXSM
Axsome Therapeutics Inc
Biopharmaceutical company developing CNS therapies
CUSIP: 05464T104
Healthcare
US
1 holder
Ownership
Activity
2025 Q2
2 of 3 quarters
Total Value
$11.20M
Total Shares
107.3K
Net Share Change
+64.5K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Bridgewater Associates LP
$11.20M
107.3K
0.0%
ADD
+64.5K
(+150.5%)
Bridgewater Associates LP
$11.20M
107.3K shares
ADD
+64.5K
(+150.5%)
AXSM — Axsome Therapeutics Inc - FilingSpy